Background and aims: Several studies have shown that endothelial dysfunction plays a role in the pathogenesis of Takotsubo syndrome (TTS). Given the potential benefit of statin therapy on endothelial dysfunction, we hypothesized that such treatment could improve outcome. Aim of our study was to evaluate clinical characteristics and outcome of TTS patients treated with statin therapy. Methods: Patients were enrolled in the international multicenter GEIST (GErman Italian Spanish Takotsubo) registry. Demographic data, clinical features and drug therapy at discharge were recorded. Primary study outcome was the occurrence of all-cause death at follow-up. Results: Study population included 2429 consecutive TTS patients: 1293 (53.2%) discharged on statin and 1136 (46.8%) without statin. Patients with statin were older (age 72 ± 11 vs 69 ± 13 years, p < 0.001), with higher prevalence of hypertension (74.3% vs 60.3%, p < 0.001), diabetes (21.1% vs 14.7%, p < 0.001), dyslipidemia (56.1% vs 23.3%, p < 0.001), history of coronary artery disease (13.3% vs 6.3%, p < 0.001) and lower rates of in-hospital complications (14.7% vs 19.3%, p = 0.003). Survival analysis showed similar mortality rates between groups (log rank p = 0.803). At univariable analysis, statin therapy at discharge was not associated with lower mortality (HR: 0.97, 95% CI 0.74–1.26, p = 0.803). At multivariable analysis age (HR: 1.06 95% CI 1.04–1.08, p < 0.001), male sex (HR: 1.83, 95% CI 1.20–2.80, p = 0.005), diabetes (HR: 2.55, 95% CI 1.83–3.54 p < 0.001), malignancies (HR: 2.41, 95% CI 1.68–3.44, p < 0.001) and physical trigger (HR: 2.24, 95% CI 1.62–3.10, p < 0.001) were associated with increased mortality. Conclusions: Statin therapy after a TTS event was not associated with better prognosis at follow-up.

Statin therapy and outcome in Takotsubo syndrome patients: Results from the multicenter international GEIST registry / Novo, G.; Arcari, L.; Stiermaier, T.; Alaimo, C.; El-Battrawy, I.; Cacciotti, L.; Guerra, F.; Musumeci, B.; Mariano, E.; Parisi, G.; Montisci, R.; Vazirani, R.; Perez Castellanos, A.; Uribarri, A.; Corbi-Pascual, M.; Salamanca, J.; Akin, I.; Thiele, H.; Brunetti, N. D.; Eitel, I.; Nunez Gil, I. J.; Santoro, F.. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 389:(2024). [10.1016/j.atherosclerosis.2023.117421]

Statin therapy and outcome in Takotsubo syndrome patients: Results from the multicenter international GEIST registry

Arcari L.
Co-primo
;
Alaimo C.;Musumeci B.;Mariano E.;
2024

Abstract

Background and aims: Several studies have shown that endothelial dysfunction plays a role in the pathogenesis of Takotsubo syndrome (TTS). Given the potential benefit of statin therapy on endothelial dysfunction, we hypothesized that such treatment could improve outcome. Aim of our study was to evaluate clinical characteristics and outcome of TTS patients treated with statin therapy. Methods: Patients were enrolled in the international multicenter GEIST (GErman Italian Spanish Takotsubo) registry. Demographic data, clinical features and drug therapy at discharge were recorded. Primary study outcome was the occurrence of all-cause death at follow-up. Results: Study population included 2429 consecutive TTS patients: 1293 (53.2%) discharged on statin and 1136 (46.8%) without statin. Patients with statin were older (age 72 ± 11 vs 69 ± 13 years, p < 0.001), with higher prevalence of hypertension (74.3% vs 60.3%, p < 0.001), diabetes (21.1% vs 14.7%, p < 0.001), dyslipidemia (56.1% vs 23.3%, p < 0.001), history of coronary artery disease (13.3% vs 6.3%, p < 0.001) and lower rates of in-hospital complications (14.7% vs 19.3%, p = 0.003). Survival analysis showed similar mortality rates between groups (log rank p = 0.803). At univariable analysis, statin therapy at discharge was not associated with lower mortality (HR: 0.97, 95% CI 0.74–1.26, p = 0.803). At multivariable analysis age (HR: 1.06 95% CI 1.04–1.08, p < 0.001), male sex (HR: 1.83, 95% CI 1.20–2.80, p = 0.005), diabetes (HR: 2.55, 95% CI 1.83–3.54 p < 0.001), malignancies (HR: 2.41, 95% CI 1.68–3.44, p < 0.001) and physical trigger (HR: 2.24, 95% CI 1.62–3.10, p < 0.001) were associated with increased mortality. Conclusions: Statin therapy after a TTS event was not associated with better prognosis at follow-up.
2024
Endothelial dysfunction; Outcome; Prognosis; Statin; Stress cardiomyopathy; Takotsubo syndrome
01 Pubblicazione su rivista::01a Articolo in rivista
Statin therapy and outcome in Takotsubo syndrome patients: Results from the multicenter international GEIST registry / Novo, G.; Arcari, L.; Stiermaier, T.; Alaimo, C.; El-Battrawy, I.; Cacciotti, L.; Guerra, F.; Musumeci, B.; Mariano, E.; Parisi, G.; Montisci, R.; Vazirani, R.; Perez Castellanos, A.; Uribarri, A.; Corbi-Pascual, M.; Salamanca, J.; Akin, I.; Thiele, H.; Brunetti, N. D.; Eitel, I.; Nunez Gil, I. J.; Santoro, F.. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 389:(2024). [10.1016/j.atherosclerosis.2023.117421]
File allegati a questo prodotto
File Dimensione Formato  
Novo_Statin_2024.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.43 MB
Formato Adobe PDF
1.43 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1712063
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact